Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Free Cash Flow: 2017-2025

Historic Free Cash Flow for Arcus Biosciences (RCUS) over the last 9 years, with Sep 2025 value amounting to -$97.0 million.

  • Arcus Biosciences' Free Cash Flow fell 488.00% to -$97.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$464.0 million, marking a year-over-year decrease of 174.56%. This contributed to the annual value of -$176.0 million for FY2024, which is 46.67% up from last year.
  • According to the latest figures from Q3 2025, Arcus Biosciences' Free Cash Flow is -$97.0 million, which was up 27.07% from -$133.0 million recorded in Q2 2025.
  • Arcus Biosciences' 5-year Free Cash Flow high stood at $651.0 million for Q1 2022, and its period low was -$133.0 million during Q1 2025.
  • Over the past 3 years, Arcus Biosciences' median Free Cash Flow value was -$94.0 million (recorded in 2024), while the average stood at -$79.0 million.
  • Per our database at Business Quant, Arcus Biosciences' Free Cash Flow soared by 1,030.57% in 2022 and then slumped by 2,116.67% in 2025.
  • Quarterly analysis of 5 years shows Arcus Biosciences' Free Cash Flow stood at -$70.4 million in 2021, then climbed by 0.51% to -$70.0 million in 2022, then crashed by 34.29% to -$94.0 million in 2023, then decreased by 7.45% to -$101.0 million in 2024, then slumped by 488.00% to -$97.0 million in 2025.
  • Its last three reported values are -$97.0 million in Q3 2025, -$133.0 million for Q2 2025, and -$133.0 million during Q1 2025.